ANEB
Anebulo Pharmaceuticals, Inc.
0.00 (0.00%)0.36USD100成交股數14.7M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 6 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | 36K-64% | 100K-100% | 100K | – | 100K | 32.0M | 0 | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.2M | 810K | 638K | 1.2M | 1.3M | 468K | 748K | 1.1M | 1.3M | 1.1M | 1.9M | 1.2M |
| 銷售管理費用 | 1.5M | 1.5M | 1.3M | 1.4M | 1.1M | 873K | 916K | 1.7M | 1.3M | 1.8M | 1.9M | 1.4M |
| 營業利益 | −2.6M+9% | −2.3M+69% | −1.9M+14% | −2.6M-6% | −2.4M-5% | −1.3M-53% | −1.7M-56% | −2.8M+6% | −2.5M | −2.9M | −3.8M | −2.6M |
| 營業利益率 | – | – | -5,256.5% | -2,588.2% | -2,412.1% | – | -1,664.3% | -8.6% | – | – | – | – |
| 稅後淨利 | −2.0M-9% | −2.2M+60% | −1.7M+1% | −2.5M-9% | −2.2M-11% | −1.3M-52% | −1.7M-57% | −2.7M+4% | −2.5M | −2.8M | −3.8M | −2.6M |
| 淨利率 | – | – | -4,656.0% | -2,463.0% | -2,200.7% | – | -1,653.5% | -8.5% | – | – | – | – |
| 稀釋 EPS | -0.05-38% | -0.050% | -0.04-33% | -0.09-18% | -0.08-20% | -0.05-55% | -0.06-60% | -0.110% | -0.10 | -0.11 | -0.15 | -0.11 |
| 稀釋股數 | 41.1M | 41.1M | 41.1M | 27.4M | 25.9M | 25.8M | 25.9M | 25.8M | 25.6M | 25.6M | 25.6M | 23.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 9.0M | 10.4M | 13.3M | 15.0M | 1.4M | 3.1M | 5.1M | 6.6M | 8.5M | – | – | – |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 9.4M | 10.7M | 14.0M | 15.8M | 2.5M | 4.1M | 6.0M | 7.5M | 9.0M | 14.4M | 16.9M | 19.8M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 1.5M | 964K | 546K | 879K | 569K | 261K | 1.0M | 1.0M | 717K | 1.5M | 1.4M | 698K |
| 股東權益 | 7.9M | 9.7M | 13.5M | 15.0M | 1.9M | 3.8M | 5.0M | 6.5M | 8.3M | 12.9M | 15.5M | 19.1M |
| 負債比 | 15.8% | 9.0% | 3.9% | 5.5% | 23.1% | 6.4% | 16.9% | 13.5% | 7.9% | 10.3% | 8.1% | 3.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.3M | – | – | −1.7M-38% | – | – | – | −2.7M | – | – | −2.0M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −8.5M | –% | -0.25 | – |
| FY2024 | – | – | −8.2M | –% | -0.32 | – |
| FY2023 | – | – | −11.7M | –% | -0.47 | – |
| FY2022 | – | – | −6.8M | –% | 0.29 | – |
| FY2021 | – | – | −30.3M | –% | -2.83 | – |